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SUMMARY 
Background:  Primary malignant melanoma rarely 
arises from noncutaneous tissues that contain melano-
cytes. Head and neck mucosal melanomas account for 
0.7% to 3.8% of all melanomas. Here we report a case 
of primary malignant melanoma of aryepiglottic fold.	
Result: Here we reported a case of primary malignant 
melanoma of aryepiglottic fold. 
Conclusion: Primary aryepiglottic fold melanoma is an 
exceptionally rare neoplasm with early distant metasta-
ses and aggressive fatal course. Early diagnosis and 
proper line of treatment are crucial for survival. Physi-
cians should keep a high index of suspicion for diagno-
sis of this rare tumor especially in old age with pig-
mented or non-pigmented lesion in larynx.  
 
INTRODUCTION 
Melanomas are mostly cutaneous in origin. Primary 
malignant melanoma occasionally arises from noncuta-
neous tissues that contain melanocytes, such as lep-
tomeninges, uvea, and gastrointestinal, respiratory, and 
genitourinary tracts. Head and neck mucosal melano-
mas account for 0.7% to 3.8% of all melanomas.1 Pri-
mary malignant melanoma of the mucosa is more 
common than secondary metastatic disease and occur-
ring more commonly in the nasal cavity and the maxil-
la.  
 
However, melanoma metastatic to the mucosa of the 
head and neck region has been documented most 
commonly in larynx, tongue, and tonsil.2 Primary mel-
anoma of the larynx and trachea are very rare among 
the group of non-cutaneous melanomas. In primary 
melanoma of the larynx, the least common site is the 
subglottic mucosa.3 Here we present a case of primary 
malignant melanoma of aryepiglottic fold. 
 
CASE REPORT 
A 70 year old woman, with no significant past medical 
history, presented to Otorhinolaryngology outpatient 
department of our hospital due to progressive change 
of voice (hoarseness) for the past four months. She had 
no history of dysphagia, odynophagia, and otalgia. 
There was no symptom of obstructive lung disease. On 
examination, direct and indirect laryngoscopy revealed 
a pigmented and ulcerated lesion involving the aryepi-
glottic folds. Computed tomography (CT) scan of the 
neck confirmed aryepiglottic lesion.  
 
Biopsy of the ulcerated lesion revealed sheets of ma-
lignant melanin containing cells involving the overly-
ing squamous mucosa and extending into the lamina 
propria. The nuclei were significantly pleomorphic 
with prominent nucleoli and mitotic figures. The im-
mune profile of neoplastic cells was strongly positive 
for HMB-45, S-100, vimentin and negative for cy-
tokeratin, synoptophysin and CD34.  Extensive physi-
cal examination by a dermatologist and nuclear imag-
ing including positron emission tomography (PET) 
scan failed to reveal a primary source of malignant 
melanoma. So, the patient was diagnosed as primary 
malignant melanoma of aryepiglottic mucosa. 
 
 
Figure 1 Photomicrograph showing origin of melano-
ma (H&E, 100x) 
 
 
Figure 2 Photomicrograph showing sheets of melano-




















Head and neck mucosal melanomas account for 0.7% 
to 3.8% of all melanomas. Majority of patients are 
white males in their sixth or seventh decade of life. 
Smoking is a major risk factor, but exposure to sun-
light, human papilloma virus, chronic irritants, and 
carcinogenic compounds also play a role in pathogene-
sis of melanomas. Recently, several studies reported 
that malignant melanomas are result of an altered im-
mune system, and many genes have been involved in 
its pathogenesis but this is not confirmed yet.1 Recent 
studies have shown an involvement of immune system 
dysregulation in mucosal melanomas with identifica-
tion of certain genes like interleukin (IL17A) and 
CD70. This can be helpful in development of effective 
adjuvant immunotherapy for the treatment of melano-
mas.1,3 
 
Patients with primary malignant melanoma of the lar-
ynx usually present with complaints of hoarseness of 
voice and sore throat. If the size of tumor increases and 
obstructs the lumen of larynx, it can cause respiratory 
distress. Differentiation of primary from the secondary 
lesion may be challenging, especially as melanoma 
may sometime disappear from primary site after metas-
tasis. On gross examination, cut surface of malignant 
melanoma may have slate gray, brown, or black pig-
mentation, which may be a clue to diagnosis.1,3 
 
 
Histopathological examination of tissue sections is 
needed for the diagnosis of melanoma. Hematoxylin 
and eosin staining typically shows pleomorphic, epithe-
lioid, and/or spindle shaped malignant cells extending 
into adjacent lateral and overlying mucosa. Cells often 
contain dark brown cytoplasmic and nuclear melanin, 
however, some lesions are amelanotic. Presence of 
positivity of melanoma markers as S-100, HMB-45, 
Melan-A, and PNL-2 in melanoma cells through im-
munohistochemical staining is needed for confirmation 
of the diagnosis especially in amelanotic melanoma. 
Electron microscopy may identify the presence of mel-
anosomes or premelanosomes. PET scan and/or mag-
netic resonance imaging (MRI) can be used to stage 
primary melanoma.1,3 
 
As compared to their cutaneous counterparts, mucosal 
melanomas are more aggressive and have worse prog-
nosis with overall 5-year survival of less than 20%. 
Poor prognosis is typically associated with early 
presentation of distant metastases. The treatment for 
mucosal melanomas of head and neck, including laryn-
geal lesions, is complete surgical excision, but some-
times it is difficult because of proximity of tumor to 
critical structures. Postoperative radiation therapy to 
the affected area has been effective in local spread of 
tumor in several retrospective series.  
 
Gaissert et al performed a retrospective review of 360 
primary tracheal tumors, in which only 1 patient was 
identified with tracheal melanoma. In a review of 259 
cases of head and neck mucosal melanomas, the most 
common mucosal sites were the nasal cavity (69%) and 
the oral cavity (22%).4 Of the reported cases of primary 
laryngeal melanoma in the literature, Terada et al re-
viewed 38 patients, and found 80% were male, the 
mean age was 60 years, and the supraglottis was the 
most common primary site. The diagnosis of a head 
and neck mucosal melanoma is established through 
histopathological examination of biopsy. Criteria have 
been proposed for the differentiation of primary versus 
metastatic melanoma of the larynx and trachea.5 Durai 
et al reported a case of primary malignant melanoma of 
the epiglottis.6 
 
Primary aryepiglottic fold melanoma is an exceptional-
ly rare neoplasm with early distant metastases and ag-
gressive fatal course. Early diagnosis and proper line of 
treatment are crucial for survival. Physicians should 
keep a high index of suspicion for diagnosis of this rare 
tumor especially in old age with pigmented or non 
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